HIV Clinical Trials in San Francisco, California

12 studies are recruiting for hiv in San Francisco, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Liver Transplantation From Donors With HIV: Impact on Opportunistic Infections, Cancer, and Long-Term Outcomes (Expanding HOPE Liver)

   This research is being done to better understand opportunistic infections and cancer in transplant recipients with HIV who receive livers from a donor with HIV compared to livers from donors without HIV.

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of California, San Francisco, San Francisco, California

   Locations

   19 in total

   Run by

   Johns Hopkins University

   See if you can join NCT07665372 on ClinicalTrials.gov

2. A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1

   This study is testing a lab-made antibody called ePGT121v1-LS that targets a specific part of HIV. Researchers will give it by vein (IV) and under the skin (SC), both on its own and together with two other antibodies, VRC07-523LS and PGDM1400LS, which target different parts of the virus. They will …

   Stage

   Phase 1

   Ages

   18 to 55

   Site

   Bridge HIV CRS (Site ID: 30305), San Francisco, California

   Locations

   11 in total

   Run by

   National Institute of Allergy and Infectious Diseases (NIAID)

   See if you can join NCT07390955 on ClinicalTrials.gov

3. CHAMPION: Combining HIV And Meth Prevention and Treatment Interventions Optimized for HIV-Negative MSM

   The goal of this randomized controlled trial is to pilot test new mobile health (mHealth) interventions to improve PrEP adherence among HIV-negative men who have sex with men (MSM) with mild to moderate methamphetamine use disorder (MUD). The CHAMPION intervention combines two mHealth tools-PrEPAPP…

   Stage

   Not phased

   Ages

   18 to 40

   Site

   Center on Substance Use and Health, San Francisco, California

   Run by

   University of California, San Diego

   See if you can join NCT07213258 on ClinicalTrials.gov

4. Small Trial of Alendronate Impact on the Reservoir of HIV

   This clinical trial is designed to test the effects of alendronate (ALN) on people living with HIV who are already receiving antiretroviral therapy (ART). Participants are randomly assigned in a 2:1 ratio to either receive alendronate or a placebo, and neither the participants nor the researchers k…

   Stage

   Phase 2

   Ages

   18 to 65

   Site

   University of California, San Francisco HIV/AIDS (Site ID: 801), San Francisco, California

   Locations

   5 in total

   Run by

   National Institute of Allergy and Infectious Diseases (NIAID)

   See if you can join NCT07216794 on ClinicalTrials.gov

5. Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)

   This research is being done to better understand rejection in transplant recipients with HIV who receive kidneys from donors with vs without HIV.

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of California, San Francisco, San Francisco, California

   Locations

   18 in total

   Run by

   Johns Hopkins University

   See if you can join NCT06263426 on ClinicalTrials.gov

6. The Use of Leukapheresis to Support HIV Pathogenesis Studies

   Despite the dramatic improvements that have resulted from combination antiretroviral treatment, long-term efficacy, toxicity, cost, and the requirements for life-long adherence remain as formidable challenges. Also, there is emerging consensus that persistent HIV-associated disease occurs during lo…

   Stage

   Not phased

   Ages

   18 and older

   Site

   San Francisco General Hospital, San Francisco, California

   Run by

   University of California, San Francisco

   See if you can join NCT01161199 on ClinicalTrials.gov

7. The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

   HIV medicines have led to dramatic improvements in health. However, there remains a concern for potential drug toxicities, cost of drugs, and need for life-long treatment. In addition, research has found that health is not completely restored in HIV-infected patients, even if they have been taking …

   Stage

   Not phased

   Ages

   18 to 70

   Site

   San Francisco General Hospital, San Francisco, California

   Run by

   University of California, San Francisco

   See if you can join NCT01202305 on ClinicalTrials.gov

8. The Synergistic Effects of Menopause and HIV on Cardiovascular Disease Risk in Women

   Menopause is associated with the acceleration of many comorbidities, including cardiovascular disease. Whether HIV and menopause together increase cardiovascular disease risk is a key knowledge gap. The goal of this observational study is to address this knowledge gap by looking at the role of meno…

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of California, San Francisco, San Francisco, California

   Run by

   University of California, San Francisco

   See if you can join NCT07284082 on ClinicalTrials.gov

9. Collection of Blood for Multiple Collaborative Studies

   This study seeks to confidentially collect blood from HIV-positive individuals and HIV-negative controls to provide basic scientists with specimens for collaborative studies.

   Stage

   Not phased

   Ages

   18 and older

   Site

   San Francisco General Hospital, San Francisco, California

   Run by

   University of California, San Francisco

   See if you can join NCT01336855 on ClinicalTrials.gov

10. Multidisciplinary Low-Barrier and Mobile HIV Care to Improve Retention and Viral Suppression: Stakeholder-Engaged Design and Evaluation

    The purpose of this study is to evaluate the implementation and effectiveness of a flexible, multidisciplinary, integrated drop-in/mobile HIV care approach for people living with HIV (PLH) who are not well engaged in current care systems (i.e. scheduled HIV primary care visits). The hybrid type 2 i…

    Stage

    Not phased

    Ages

    15 and older

    Site

    San Francisco AIDS Foundation, San Francisco, California

    Locations

    5 in total

    Run by

    University of California, San Francisco

    See if you can join NCT05887557 on ClinicalTrials.gov

11. Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good Health

    This is a partially randomized, open-label phase 1 study to evaluate the safety and immunogenicity of a priming regimen of 426c.Mod.Core-C4b adjuvanted with 3M-052 AF + Alum followed by boosts with HxB2.WT.Core-C4b adjuvanted with 3M-052 AF + Alum. The primary hypothesis is that the boosting with H…

    Stage

    Phase 1

    Ages

    18 to 55

    Site

    Bridge HIV, San Francisco Department of Public Health, San Francisco, California

    Locations

    6 in total

    Run by

    National Institute of Allergy and Infectious Diseases (NIAID)

    See if you can join NCT06796686 on ClinicalTrials.gov

12. Text Education About Cardiovascular Health and HIV (TEACH-HIV)

    The overall objective is to evaluate the efficacy of educational text messages to reduce cardiovascular risk among persons living with HIV (PLWH).

    Stage

    Not phased

    Ages

    40 and older

    Site

    Zuckerberg San Francisco General Hospital, San Francisco, California

    Locations

    2 in total

    Run by

    University of California, San Francisco

    See if you can join NCT05642858 on ClinicalTrials.gov